MedPath

AURO-CEFIXIME

AURO-CEFIXIME

Approved
DIN Number

02468689

Drug Class

Human

Market Date

Jan 8, 2018

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02468689
AIG Number0122105001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD08 CEFIXIME
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationOral
AHFS Classification08:12.06.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEFIXIMEActive
Strength: 100 MG / 5 ML
Monograph: CEFIXIME

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.